Cor Vasa 2006, 48(2):72-74 | DOI: 10.33678/cor.2006.025
Další informace o studii FIELD (Fenofibrate Intervention and Event Lowering in Diabetes]
Published: February 1, 2006 Show citation
References
- The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-61.
Go to original source...
Go to PubMed...
- Colhoun H. After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes? Lancet 2005; 366:1829-31.
Go to original source...
Go to PubMed...
- Colhoun HM, Betteridge DJ, Durrington PN, for the CARDS Group. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96.
Go to original source...
Go to PubMed...
- Collins R, Armitage J, Parish S. for the Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-16.
Go to original source...
Go to PubMed...